Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05878184
Title Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sana Biotechnology
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Stanford Cancer Institute Palo Alto California 94304 United States Details
Northside Hospital Atlanta Georgia 30342 United States Details
University of Kansas Medical Center Fairway Kansas 66205 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
University of Nebraska Medical Center Omaha Nebraska 68198 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Royal Adelaide Hospital Adelaide South Australia 5000 Australia Details
Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia Details
Linear Clinical Research Ltd Nedlands Western Australia 6009 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field